Trials / Active Not Recruiting
Active Not RecruitingNCT05243836
S.T.O.P.® Technology Contact Lenses Versus Dual-focus Contact Lenses for Slowing Down Myopia Progression in Children
Contact Lenses Utilising S.T.O.P.® Technology Versus Dual-focus Contact Lenses for Slowing Down Myopia Progression in Children: A Three-year Prospective, Multi-centre, Controlled, Masked, Randomised, Non Inferiority Clinical Trial
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 441 (estimated)
- Sponsor
- nthalmic Pty Ltd · Network
- Sex
- All
- Age
- 8 Years – 14 Years
- Healthy volunteers
- Not accepted
Summary
To compare the rate of myopia progression of contact lenses utilising S.T.O.P.® technology against MiSight® contact lenses.
Detailed description
Myopic children (8-14 years of age) will be randomly allocated to wear one of 3 contact lens options (MiSight®, S.T.O.P.®- F2 or S.T.O.P.®- DT) bilaterally on a daily wear basis. The overall trial duration, including follow-up period, is expected to be approximately 48 months. Each participant's duration is expected to be approximately 36 months. The visits are Baseline / Fit, Dispensing, 1 week, 1 month, 6 months then visits every 6 months after. All procedures performed at these visits are standard, non invasive clinical tests.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | S.T.O.P® F2 | Ocufilcon D, 55% water |
| DEVICE | S.T.O.P® DT | Ocufilcon D, 55% water |
| DEVICE | MiSight® | Omafilcon A (60% water) |
Timeline
- Start date
- 2023-08-04
- Primary completion
- 2028-01-01
- Completion
- 2028-01-01
- First posted
- 2022-02-17
- Last updated
- 2026-03-05
Locations
7 sites across 3 countries: China, India, Spain
Source: ClinicalTrials.gov record NCT05243836. Inclusion in this directory is not an endorsement.